Fri, Jul 25, 2014, 3:25 AM EDT - U.S. Markets open in 6 hrs 5 mins

Recent

% | $
Click the to save as a favorite.

Becton, Dickinson and Company Message Board

  • vanishpiontinvestor vanishpiontinvestor Jan 19, 2009 1:18 AM Flag

    Integra Patent Infringement

    http://google.brand.edgar-online.com/EFX_dll/EDGARpro.dll?FetchFilingHTML1?SessionID=cRlTWgicTV3vd1B&ID=5252353

    BD’s Integra syringes infringe Retractable’s patents. Like VanishPoint ® syringes, Integra syringes have a spring loaded needle that is fired by continuing to push the plunger after the injection is complete. This releases the needle holder from a retaining ring so the needle retracts back into the syringe body. The Integra syringes also use the same “breakaway” feature for releasing the needle holder from the retainer ring that is taught in Retractable’s patents. The Integra 3 cc syringe has a plunger thumb cap that tucks down into the top of the syringe barrel so that it cannot be easily pulled out and reused, and has vents to relieve air pressure from the retraction cavity and prevent splattering when the needle is retracted. These features are disclosed and claimed in Retractable’s patents.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • In late 2003, when BD paid some pocket change to RVP, BD stock was trading at $37 and RVP stock close to $9.

      Since then, BD stock has risen by over 100%, doubling in value. RVP stock, on the other hand, has plummeted by a whopping 94%.

      Is this due to the patent infringement?

 
BDX
118.49-0.12(-0.10%)Jul 24 4:03 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.